-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
According to the National Public Radio (NPR) report, the latest research shows that after some people are infected with the new crown virus, after two doses of Pfizer or Moderna vaccine, the body's immune system will produce a large number of antibodies
In short, contracting the new coronavirus in 2020 + receiving two doses of mRNA vaccine in 2021 = superhuman immunity
This study mainly studied the plasma samples of 14 people
Rockefeller University (Rockefeller University) virologist Paul Bieniasz said: "We can reasonably speculate that these people can fight most of the new coronavirus mutants, and even all of them
According to their research, the antibodies of several subjects can strongly neutralize the six new coronavirus variants they tested, including the Delta variant first released in India and the Beta variant first released in South Africa
Prior to this, a study published in the journal Nature in June this year showed that both Pfizer and Moderna's mRNA COVID-19 vaccines can provide a "strong and long-lasting" immune response that can last for several years or even life-long protection
A total of 41 people were recruited for this study.
These participants also developed high levels of neutralizing antibodies to the Alpha variant originally found in the UK and the Beta variant originally found in South Africa
Ali Ellebedy, an immunologist who participated in the study, said that although only people who had been vaccinated by Pfizer were studied, this finding also applies to Moderna because the two vaccines use the same technology
There is also news that due to long-term immunization, it may not even be necessary to get a third shot
However, the United States plans to open the third dose of COVID-19 vaccine starting on September 20
The plan was jointly developed by the US Centers for Disease Control and Prevention (CDC) and the US Food and Drug Administration (FDA)
In fact, Israel started to inject the third dose of Pfizer's vaccine on the 1st, and announced the results of the third dose of vaccine at the end of August
This study analyzed the protective effects of 149,144 people over 60 who received the third dose of the vaccine at least a week ago
According to reports, Pfizer’s third dose of vaccine has greatly improved the protection of Israelis aged 60 and above, increasing their ability to avoid infection and serious diseases by 86%
However, Salman Zarka, Israel’s national epidemiological prevention consultant, said on September 4 that due to the raging epidemic, “we need to prepare a fourth dose of vaccine
"If super immunity can emerge, that would be great news
.
I hope this epidemic will end soon
.
"